A clinical algorithm to determine target blood pressure in the elderly: evidence and limitations from a clinical perspective
- PMID: 35701854
- PMCID: PMC9199158
- DOI: 10.1186/s40885-022-00202-9
A clinical algorithm to determine target blood pressure in the elderly: evidence and limitations from a clinical perspective
Abstract
As the elderly population is growing rapidly, management of hypertension in South Korea faces major challenges because the proportion of elderly hypertension patients is also increasing. The characteristics of this population are also much more complex than younger patients. Elderly hypertension is characterized by wide variations in (1) fitness or biological age, (2) white-coat effect, (3) poor functional status or frailty, (4) dependency in activities of daily living or institutionalization, (5) orthostatic hypotension, and (6) multiple comorbidities. All of these should be considered when choosing optimal target blood pressure in individual patients. Recent randomized clinical trials have shown that the benefits of intensive blood pressure control for elderly patients is greater than previously thought. For generalization of these results and implementation of the guidelines based on these studies, defining the clinician's role for individualization is critically important. For individualized decisions for target blood pressure (BP) in the elderly with hypertension, four components should first be checked. These consist of (1) the minimum requirement of functional status and capability of activities of daily living, (2) lack of harmful evidence by the target BP, (3) absence of white-coat hypertension, and (4) standing systolic BP ≥ 110 mmHg without orthostatic symptoms. Risk of decreased organ perfusion by arterial stenosis should be screened before starting intensive BP control. When the target BP differs among comorbidities, the lowest target BP should be given preference. After starting intensive BP lowering therapy, tolerability should be monitored, and the titration should be based on the mean level of blood pressure by office supplemented by out-of-office BPs. Applications of the clinical algorithms will be useful to achieve more standardized and simplified applications of target BP in the elderly.
Keywords: Aged; Algorithms; Antihypertensives agents; Frailty; Hypertension; Hypotension.
© 2022. The Author(s).
Conflict of interest statement
Jinho Shin received grants from Sanofi and Hanmi and honoraria from Sankyo, Menarini, Daewoong, Boryong, Daewon, Bayer, Viatris, and Dongwha. Kwang-il Kim received research grants from Hanmi, Boryong, Sankyo and honoraria from Sankyo, Daewoong, Boryong, Viatris.
Figures


Similar articles
-
Treatment of Hypertension: Which Goal for Which Patient?Adv Exp Med Biol. 2017;956:117-127. doi: 10.1007/5584_2016_97. Adv Exp Med Biol. 2017. PMID: 27722961 Review.
-
Characteristics According to Frailty Status Among Older Korean Patients With Hypertension.J Korean Med Sci. 2024 Mar 18;39(10):e84. doi: 10.3346/jkms.2024.39.e84. J Korean Med Sci. 2024. PMID: 38501181 Free PMC article. Clinical Trial.
-
Should blood pressure goal be individualized in hypertensive patients?Pharmacol Res. 2017 Apr;118:53-63. doi: 10.1016/j.phrs.2016.11.037. Epub 2016 Dec 2. Pharmacol Res. 2017. PMID: 27919826 Review.
-
STEP to blood pressure management of elderly hypertension: evidence from Asia.Hypertens Res. 2022 Apr;45(4):576-582. doi: 10.1038/s41440-022-00875-7. Epub 2022 Mar 11. Hypertens Res. 2022. PMID: 35277670 Free PMC article. Review.
-
What Should Be the Target Blood Pressure in Elderly Patients With Diabetes?Diabetes Care. 2016 Aug;39 Suppl 2:S234-43. doi: 10.2337/dcS15-3027. Diabetes Care. 2016. PMID: 27440838
Cited by
-
Blood Pressure Target in Type 2 Diabetes Mellitus.Diabetes Metab J. 2022 Sep;46(5):667-674. doi: 10.4093/dmj.2022.0215. Epub 2022 Sep 19. Diabetes Metab J. 2022. PMID: 36193727 Free PMC article. Review.
-
Clinical and epidemiological implications of the data on the Korean clinical hypertension cohort.Korean J Intern Med. 2023 Jan;38(1):5-6. doi: 10.3904/kjim.2022.371. Epub 2022 Dec 28. Korean J Intern Med. 2023. PMID: 36596759 Free PMC article. No abstract available.
References
-
- World Health Organization (WHO). A global brief on hypertension: silent killer, global public health crisis: World Health Day 2013 [Internet]. Geneva: WHO; 2013 [cited 3 February 2022]. Available from: https://apps.who.int/iris/handle/10665/79059.
-
- Buckley LF, Dixon DL, Wohlford GF, 4th, Wijesinghe DS, Baker WL, Van Tassell BW. Intensive versus standard blood pressure control in SPRINT-eligible participants of ACCORD-BP. Diabetes Care. 2017;40:1733–8. - PubMed
-
- World Health Organization (WHO) Global health and aging. Geneva: WHO; 2011.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials